EPS

As Wix prepares for a key investor chat, all eyes are on its AI strategy, recent market turbulence, and its path to sustained profitable growth.

With a key gene therapy approval imminent and major clinical data on deck, REGENXBIO's upcoming financial report will be a crucial test for the biotech.

The bank's Q1 earnings surge to $1.25B, driven by its Canadian Western Bank takeover and strategic deals, signaling aggressive pan-Canadian expansion.

Fresh off record profits, World Gym details its strategy for global growth, betting on AI health platforms and high-margin services to reshape the industry.

The professional information giant posted robust 2025 earnings while ramping up AI investment and navigating a pivotal CEO transition. Here's what it means.

With a 61% profit surge, the Dutch tank storage giant rewards investors while launching a €4B plan to dominate both traditional and green energy infrastructure.

The insurer's profits skyrocketed over 1,000% in Q4, signaling a dramatic turnaround fueled by legislative changes and shrewd strategic maneuvers.

Archrock crushes profit estimates and hikes its dividend, signaling strong confidence as it positions to power the soaring energy demands of LNG and AI.

The life sciences giant's significant dividend hike underscores its robust financial health and commitment to growth, even as it pursues major acquisitions.

Fueled by policy incentives and strong demand, First Solar reports robust 2025 growth and accelerates its US factory expansion, cementing its market leadership.

All eyes are on Micron's March 18 report as a key test of the AI-fueled memory market recovery and the firm's strategic pivot to high-value tech.

Euroholdings declared a dividend on solid Q4 results, but a $10.2M one-time gain skews its full-year profits as it bets big on the tanker market.

Latin American giant MercadoLibre posts record revenue for 2025 but misses profit estimates, sending shares lower as it invests heavily in future growth.

The tech firm announced progress on a major health contract, but with its stock near all-time lows, can this deal deliver a much-needed turnaround?

Logistics giant faces falling profits from weak ocean freight, but a diversification strategy and a massive new share buyback signal long-term confidence.

After a massive divestiture, Brightstar Lottery slashes debt, rewards investors, and sets its sights on digital expansion in Italy and Brazil.

With a record $1.2B order backlog and a bullish 2026 forecast, the specialty vehicle maker also announces a major leadership shift to drive its next growth phase.

With key conferences ahead, Supernus Pharmaceuticals must prove its strategy can deliver growth in the competitive central nervous system drug landscape.

Beam Therapeutics is set to announce its 2025 financial results and a new liver-targeted therapy, a key moment for its base editing platform and investors.

With promising data in cancer and eczema, all eyes are on Corvus Pharmaceuticals as it presents its lead drug at a major healthcare conference this week.